Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1997 Sep;73(863):538–542. doi: 10.1136/pgmj.73.863.538

Basal cell carcinoma.

J T Lear 1, A G Smith 1
PMCID: PMC2431451  PMID: 9373591

Abstract

Basal cell carcinoma is the commonest malignancy in Caucasians with incidence rates of 300 per 100,000 reported in the USA. Rates are increasing at over 10% per year leading to a lifetime risk of 30%. Although mortality is low, the disease is responsible for considerable morbidity and places a substantial burden on health service provision in the UK. Furthermore, lesions may recur and patients often develop multiple tumours giving major implications for treatment and follow-up. Four main types of basal cell carcinoma are seen: nodulo-ulcerative; pigmented; morpheaform and superficial. Diagnosis is by histological evaluation although many tumours have a characteristic clinical appearance. The differential diagnosis is large. Identified risk factors include male gender, skin type 1, red/blonde hair and increasing age. Patients with basal cell carcinoma are more likely to develop malignant melanoma and squamous cell carcinoma but it is still unclear whether there is a link with internal malignancy. The main treatment modalities are surgery and radiotherapy. Each has advantages and disadvantages. The choice of treatment depends on many factors. Principles of treatment include identification of high-risk patients to enable early detection, complete removal of the lesion, and careful follow-up to detect recurrence or new lesions. Approximately 10% of tumours recur, depending on site, size and treatment modality. Metastatic basal cell carcinoma and the association of ultraviolet radiation to basal cell carcinoma risk are reviewed.

Full text

PDF
538

Images in this article

538Figure 1
on p.538
539Figure 2
on p.539
539Figure 3
on p.539
539Figure 4
on p.539

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amonette R. A., Salasche S. J., Chesney T. M., Clarendon C. C., Dilawari R. A. Metastatic basal-cell carcinoma. J Dermatol Surg Oncol. 1981 May;7(5):397–400. doi: 10.1111/j.1524-4725.1981.tb00663.x. [DOI] [PubMed] [Google Scholar]
  2. Betti R., Inselvini E., Carducci M., Crosti C. Age and site prevalence of histologic subtypes of basal cell carcinomas. Int J Dermatol. 1995 Mar;34(3):174–176. doi: 10.1111/j.1365-4362.1995.tb01561.x. [DOI] [PubMed] [Google Scholar]
  3. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1993. CA Cancer J Clin. 1993 Jan-Feb;43(1):7–26. doi: 10.3322/canjclin.43.1.7. [DOI] [PubMed] [Google Scholar]
  4. Boyle J., MacKie R. M., Briggs J. D., Junor B. J., Aitchison T. C. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet. 1984 Mar 31;1(8379):702–705. doi: 10.1016/s0140-6736(84)92221-9. [DOI] [PubMed] [Google Scholar]
  5. Coebergh J. W., Neumann H. A., Vrints L. W., van der Heijden L., Meijer W. J., Verhagen-Teulings M. T. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: a registry-based study. Br J Dermatol. 1991 Oct;125(4):353–359. doi: 10.1111/j.1365-2133.1991.tb14171.x. [DOI] [PubMed] [Google Scholar]
  6. Cornell R. C., Greenway H. T., Tucker S. B., Edwards L., Ashworth S., Vance J. C., Tanner D. J., Taylor E. L., Smiles K. A., Peets E. A. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol. 1990 Oct;23(4 Pt 1):694–700. doi: 10.1016/0190-9622(90)70276-n. [DOI] [PubMed] [Google Scholar]
  7. Czarnecki D., Zalcberg J., Meehan C., O'Brien T., Leahy S., Bankier A., Nash C. G. Familial occurrence of multiple nonmelanoma skin cancer. Cancer Genet Cytogenet. 1992 Jul 1;61(1):1–5. doi: 10.1016/0165-4608(92)90361-b. [DOI] [PubMed] [Google Scholar]
  8. Dahl E., Aberg M., Rausing A., Rausing E. L. Basal cell carcinoma. An epidemiologic study in a defined population. Cancer. 1992 Jul 1;70(1):104–108. doi: 10.1002/1097-0142(19920701)70:1<104::aid-cncr2820700117>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  9. De Gruijl F. R., Van Der Meer J. B., Van Der Leun J. C. Dose-time dependency of tumor formation by chronic UV exposure. Photochem Photobiol. 1983 Jan;37(1):53–62. doi: 10.1111/j.1751-1097.1983.tb04433.x. [DOI] [PubMed] [Google Scholar]
  10. Dixon A. Y., Lee S. H., McGregor D. H. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol. 1993 Apr;20(2):137–142. doi: 10.1111/j.1600-0560.1993.tb00230.x. [DOI] [PubMed] [Google Scholar]
  11. Fleming I. D., Amonette R., Monaghan T., Fleming M. D. Principles of management of basal and squamous cell carcinoma of the skin. Cancer. 1995 Jan 15;75(2 Suppl):699–704. doi: 10.1002/1097-0142(19950115)75:2+<699::aid-cncr2820751413>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  12. Gallagher R. P., Hill G. B., Bajdik C. D., Fincham S., Coldman A. J., McLean D. I., Threlfall W. J. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol. 1995 Feb;131(2):157–163. [PubMed] [Google Scholar]
  13. Hogan D. J., To T., Gran L., Wong D., Lane P. R. Risk factors for basal cell carcinoma. Int J Dermatol. 1989 Nov;28(9):591–594. doi: 10.1111/j.1365-4362.1989.tb02534.x. [DOI] [PubMed] [Google Scholar]
  14. Holman C. D., Armstrong B. K. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984 Feb;72(2):257–266. [PubMed] [Google Scholar]
  15. Hunter D. J., Colditz G. A., Stampfer M. J., Rosner B., Willett W. C., Speizer F. E. Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol. 1990 Oct;1(1):13–23. doi: 10.1016/1047-2797(90)90015-k. [DOI] [PubMed] [Google Scholar]
  16. Ikić D., Padovan I., Pipić N., Cajkovac V., Kusić Z., Daković N., Gregurek-Novak T., Soldo-Belić A., Spaventi S., Belicza M. Interferon reduces recurrences of basal cell and squamous cell cancers. Int J Dermatol. 1995 Jan;34(1):58–60. doi: 10.1111/j.1365-4362.1995.tb04382.x. [DOI] [PubMed] [Google Scholar]
  17. Jones R. R. Ozone depletion and cancer risk. Lancet. 1987 Aug 22;2(8556):443–446. doi: 10.1016/s0140-6736(87)90972-x. [DOI] [PubMed] [Google Scholar]
  18. Kaldor J., Shugg D., Young B., Dwyer T., Wang Y. G. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer. 1993 Apr 1;53(6):886–891. doi: 10.1002/ijc.2910530603. [DOI] [PubMed] [Google Scholar]
  19. Ko C. B., Walton S., Keczkes K., Bury H. P., Nicholson C. The emerging epidemic of skin cancer. Br J Dermatol. 1994 Mar;130(3):269–272. doi: 10.1111/j.1365-2133.1994.tb02920.x. [DOI] [PubMed] [Google Scholar]
  20. Koh H. K., Geller A. C., Miller D. R., Lew R. A. Early detection of melanoma: an ounce of prevention may be a ton of work. J Am Acad Dermatol. 1993 Apr;28(4):645–647. doi: 10.1016/s0190-9622(08)81786-0. [DOI] [PubMed] [Google Scholar]
  21. Kricker A., Armstrong B. K., English D. R., Heenan P. J. Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer. 1995 Feb 8;60(4):489–494. doi: 10.1002/ijc.2910600411. [DOI] [PubMed] [Google Scholar]
  22. Kricker A., Armstrong B. K., English D. R. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control. 1994 Jul;5(4):367–392. doi: 10.1007/BF01804988. [DOI] [PubMed] [Google Scholar]
  23. Lin A. N., Carter D. M. Skin cancer in the elderly. Dermatol Clin. 1986 Jul;4(3):467–471. [PubMed] [Google Scholar]
  24. Lindelöf B., Sigurgeirsson B., Wallberg P., Eklund G. Occurrence of other malignancies in 1973 patients with basal cell carcinoma. J Am Acad Dermatol. 1991 Aug;25(2 Pt 1):245–248. doi: 10.1016/0190-9622(91)70189-9. [DOI] [PubMed] [Google Scholar]
  25. Marghoob A. A., Slade J., Salopek T. G., Kopf A. W., Bart R. S., Rigel D. S. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer. 1995 Jan 15;75(2 Suppl):707–714. doi: 10.1002/1097-0142(19950115)75:2+<707::aid-cncr2820751415>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  26. Marks R. An overview of skin cancers. Incidence and causation. Cancer. 1995 Jan 15;75(2 Suppl):607–612. doi: 10.1002/1097-0142(19950115)75:2+<607::aid-cncr2820751402>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  27. Miller D. L., Weinstock M. A. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994 May;30(5 Pt 1):774–778. doi: 10.1016/s0190-9622(08)81509-5. [DOI] [PubMed] [Google Scholar]
  28. Møller R., Nielsen A., Reymann F. Multiple basal cell carcinoma and internal malignant tumors. Arch Dermatol. 1975 May;111(5):584–585. doi: 10.1001/archderm.1975.01630170042003. [DOI] [PubMed] [Google Scholar]
  29. Naylor M. F., Boyd A., Smith D. W., Cameron G. S., Hubbard D., Neldner K. H. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995 Feb;131(2):170–175. [PubMed] [Google Scholar]
  30. Sandström A., Larsson L. G., Damber L. Occurrence of other malignancies in patients treated for basal cell carcinoma of the skin. A cohort study. Acta Radiol Oncol. 1984;23(4):227–230. doi: 10.3109/02841868409136016. [DOI] [PubMed] [Google Scholar]
  31. Scanlon E. F., Volkmer D. D., Oviedo M. A., Khandekar J. D., Victor T. A. Metastatic basal cell carcinoma. J Surg Oncol. 1980;15(2):171–180. doi: 10.1002/jso.2930150208. [DOI] [PubMed] [Google Scholar]
  32. Silverman M. K., Kopf A. W., Grin C. M., Bart R. S., Levenstein M. J. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol. 1991 Sep;17(9):720–726. doi: 10.1111/j.1524-4725.1991.tb03425.x. [DOI] [PubMed] [Google Scholar]
  33. Snow S. N., Sahl W., Lo J. S., Mohs F. E., Warner T., Dekkinga J. A., Feyzi J. Metastatic basal cell carcinoma. Report of five cases. Cancer. 1994 Jan 15;73(2):328–335. doi: 10.1002/1097-0142(19940115)73:2<328::aid-cncr2820730216>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  34. Strickland P. T. Photocarcinogenesis by near-ultraviolet (UVA) radiation in Sencar mice. J Invest Dermatol. 1986 Aug;87(2):272–275. doi: 10.1111/1523-1747.ep12696669. [DOI] [PubMed] [Google Scholar]
  35. Svanberg K., Andersson T., Killander D., Wang I., Stenram U., Andersson-Engels S., Berg R., Johansson J., Svanberg S. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994 Jun;130(6):743–751. doi: 10.1111/j.1365-2133.1994.tb03412.x. [DOI] [PubMed] [Google Scholar]
  36. Vitasa B. C., Taylor H. R., Strickland P. T., Rosenthal F. S., West S., Abbey H., Ng S. K., Munoz B., Emmett E. A. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer. 1990 Jun 15;65(12):2811–2817. doi: 10.1002/1097-0142(19900615)65:12<2811::aid-cncr2820651234>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  37. Wei Q., Matanoski G. M., Farmer E. R., Hedayati M. A., Grossman L. DNA repair related to multiple skin cancers and drug use. Cancer Res. 1994 Jan 15;54(2):437–440. [PubMed] [Google Scholar]
  38. Wicking C., Berkman J., Wainwright B., Chenevix-Trench G. Fine genetic mapping of the gene for nevoid basal cell carcinoma syndrome. Genomics. 1994 Aug;22(3):505–511. doi: 10.1006/geno.1994.1423. [DOI] [PubMed] [Google Scholar]
  39. Wilder R. B., Shimm D. S., Kittelson J. M., Rogoff E. E., Cassady J. R. Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol. 1991 Nov;127(11):1668–1672. [PubMed] [Google Scholar]
  40. Yeh S., How S. W., Lin C. S. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer. 1968 Feb;21(2):312–339. doi: 10.1002/1097-0142(196802)21:2<312::aid-cncr2820210222>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  41. von Domarus H., Stevens P. J. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984 Jun;10(6):1043–1060. doi: 10.1016/s0190-9622(84)80334-5. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES